Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Receivables (2016 - 2025)

Historic Receivables for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to $130.8 million.

  • Orthofix Medical's Receivables rose 477.63% to $130.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $130.8 million, marking a year-over-year increase of 477.63%. This contributed to the annual value of $134.7 million for FY2024, which is 516.4% up from last year.
  • Per Orthofix Medical's latest filing, its Receivables stood at $130.8 million for Q3 2025, which was up 477.63% from $129.6 million recorded in Q2 2025.
  • Over the past 5 years, Orthofix Medical's Receivables peaked at $134.7 million during Q4 2024, and registered a low of $69.0 million during Q3 2021.
  • Moreover, its 5-year median value for Receivables was $113.3 million (2023), whereas its average is $103.6 million.
  • Its Receivables has fluctuated over the past 5 years, first tumbled by 1043.47% in 2021, then surged by 5636.71% in 2023.
  • Orthofix Medical's Receivables (Quarter) stood at $78.6 million in 2021, then increased by 5.47% to $82.9 million in 2022, then soared by 54.6% to $128.1 million in 2023, then grew by 5.16% to $134.7 million in 2024, then decreased by 2.9% to $130.8 million in 2025.
  • Its Receivables stands at $130.8 million for Q3 2025, versus $129.6 million for Q2 2025 and $131.9 million for Q1 2025.